CVE-2026-30314
RCE via OS command injection in Ridvay Code auto-approval module.
Is CVE-2026-30314 being exploited?
Not confirmed. CVE-2026-30314 does not appear in CISA's Known Exploited Vulnerabilities catalog, which records only exploitation that has been observed and reported publicly. That is evidence of absence of a report, not evidence the flaw is unattacked. EPSS currently estimates a 1.2% probability of exploitation in the next 30 days.
How severe is CVE-2026-30314?
CVE-2026-30314 is rated Critical with a CVSS score of 9.8. Severity describes how bad exploitation would be, not how likely it is: pair it with exploitation evidence before deciding what to patch first.
Is there a patch for CVE-2026-30314?
Not known from our data. No patch reference has been recorded for CVE-2026-30314, which is not the same as no patch existing — a fix may have shipped without a tagged reference, or after this record was written. The vendor advisory is the only authority on whether a fix exists, and mitigations may be available regardless.
What does CVE-2026-30314 affect?
CVE-2026-30314 affects Ridvay Code Command Auto-Approval Module. Confirm the exact affected versions against the vendor advisory before deciding you are exposed.
What should I do about CVE-2026-30314?
Patch when available; harden input parsing; disable shell command expansion.
Exploitation status reflects CISA's KEV catalog as we last synced it. Check the catalog directly.
Attackers can inject shell substitutions in arguments to force remote code execution with no user interaction.
Immediate action required